Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 2855 [2014-00714]

Download as PDF ehiers on DSK2VPTVN1PROD with NOTICES Federal Register / Vol. 79, No. 11 / Thursday, January 16, 2014 / Notices 2014–0002 in the search field and click ‘‘Search.’’ Public Comment Sign-up and Submissions to the Docket: To sign up to provide public comments or to submit comments to the docket, send information to the NIOSH Docket Office by one of the following means: Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS–C–34, 4676 Columbia Parkway, Cincinnati, Ohio 45226. Email: nioshdocket@cdc.gov. Telephone: (513) 533–8611. In the event an individual cannot attend, written comments may be submitted. The comments should be limited to two pages and submitted through https://www.regulations.gov by February 10, 2014. Efforts will be made to provide the two-page written comments received by the deadline below to the committee members before the meeting. Comments in excess of two pages will be made publicly available at https://www.regulations.gov. To view background information and previous submissions go to NIOSH docket https:// www.cdc.gov/niosh/docket/archive/ docket248.html. Policy on Redaction of Committee Meeting Transcripts (Public Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If a person making a comment gives his or her name, no attempt will be made to redact that name. NIOSH will take reasonable steps to ensure that individuals making public comments are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include a statement read at the start of the meeting stating that transcripts will be posted and names of speakers will not be redacted. If individuals in making a statement reveal personal information (e.g., medical information) about themselves, that information will not usually be redacted. The CDC Freedom of Information Act coordinator will, however, review such revelations in accordance with the Freedom of Information Act and, if deemed appropriate, will redact such information. Disclosures of information concerning third party medical information will be redacted. Contact Person For More Information: Paul J. Middendorf, Ph.D., Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail Stop E–20, Atlanta, Georgia 30345, telephone 1 (888) 982–4748; email: wtc-stac@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated VerDate Mar<15>2010 14:55 Jan 15, 2014 Jkt 232001 the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–00715 Filed 1–15–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Occupational Safety and Health Education and Research Centers (ERC) PAR 10–217, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 6:00 p.m.–7:00 p.m., February 24, 2014 (Closed) 8:00 a.m.–5:00 p.m., February 25, 2014 (Closed) 8:00 a.m.–5:00 p.m., February 26, 2014 (Closed) 8:00 a.m.–12:00 p.m., February 27, 2014 (Closed) Place: Courtyard Marriott, 130 Clairemont Drive, Decatur, Georgia 30030, Telephone: (404) 371–0204. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Occupational Safety and Health Education and Research Centers (ERC) PAR 10–217’’. Contact Person For More Information: George Bockosh, M.S., Scientific Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P–05, Pittsburgh, Pennsylvania 15236, Telephone: (412) 386–6465 and Joan F. Karr, Ph.D., Scientific Review Officer, CDC/NIOSH 1600 Clifton Road NE., Mailstop E–74, PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 2855 Atlanta, Georgia 30333, Telephone: (404) 498–2506. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–00714 Filed 1–15–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Request for Nominations of Candidates To Serve on the Advisory Committee on Breast Cancer in Young Women The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Advisory Committee on Breast Cancer in Young Women (ACBCYW). The Committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. The Secretary, HHS, acting through the Director, CDC, shall appoint to the advisory committee nominees with expertise in breast cancer, disease prevention, early detection, diagnosis, public health, social marketing, genetic screening and counseling, treatment, rehabilitation, palliative care, and survivorship in young women, or in related disciplines with a specific focus on young women. Members may be invited to serve for up to four years. The next cycle of selection of candidates E:\FR\FM\16JAN1.SGM 16JAN1

Agencies

[Federal Register Volume 79, Number 11 (Thursday, January 16, 2014)]
[Notices]
[Page 2855]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00714]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Occupational Safety and Health 
Education and Research Centers (ERC) PAR 10-217, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
Times and Dates:
6:00 p.m.-7:00 p.m., February 24, 2014 (Closed)
8:00 a.m.-5:00 p.m., February 25, 2014 (Closed)
8:00 a.m.-5:00 p.m., February 26, 2014 (Closed)
8:00 a.m.-12:00 p.m., February 27, 2014 (Closed)
    Place: Courtyard Marriott, 130 Clairemont Drive, Decatur, Georgia 
30030, Telephone: (404) 371-0204.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Occupational Safety and Health Education and Research Centers 
(ERC) PAR 10-217''.
    Contact Person For More Information: George Bockosh, M.S., 
Scientific Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop 
P-05, Pittsburgh, Pennsylvania 15236, Telephone: (412) 386-6465 and 
Joan F. Karr, Ph.D., Scientific Review Officer, CDC/NIOSH 1600 Clifton 
Road NE., Mailstop E-74, Atlanta, Georgia 30333, Telephone: (404) 498-
2506.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-00714 Filed 1-15-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.